INTRODUCTION
There are currently very few treatments to improve the neurologic outcome of individuals who sustain an acute spinal cord injury (SCI). Treatment options include urgent surgical decompression to relieve pressure on the spinal cord and aggressive augmentation of systemic blood pressure to minimize ischemia. However, improved outcomes from these approaches have not been convincingly demonstrated in randomized or controlled clinical trials, and hence they are not considered 'standards of care'. We postulate that the difficulty in unequivocally demonstrating the benefits of aggressive hemodynamic support may be due to this approach eliciting not only beneficial but also adverse effects on the injured spinal cord, depending upon the presence or absence of spinal cord compression. Our overall objective is therefore to determine how hemodynamic support of mean arterial pressure (MAP) in the presence or absence of spinal cord compression affects the vascular, metabolic, biochemical, and behavioral outcomes of traumatic SCI. We hypothesize that well-intended increases in MAP after decompression contribute to detrimental edema/swelling, hemorrhage, and increased intraparenchymal pressure, in addition to exacerbating ischemia-reperfusion injury mechanisms. To test this hypothesis, we will utilize a novel pig model of SCI, for which we have developed innovative techniques for measuring intraparenchymal spinal cord blood flow (SCBF), hydrostatic pressure, and metabolic responses over time. Achieving a better understanding of how the spinal cord responds to alterations in MAP before and after decompression will provide insights that could be deployed rapidly into clinical practice to optimize the hemodynamic management of acute SCI. Such insights have added significance for soldiers injured in combat where sophisticated therapies are likely not available and the early treatment of their SCI may be limited to basic hemodynamic resuscitation and the management of their MAP. 
KEYWORDS
•
Approved Statement of Work
The approved statement of work is described below. A Gantt chart is provided in Table 1 for reference (see page 5). Aim 1. Determine the acute vascular, metabolic, and pressure responses to SCI and longterm functional outcome. "SCI with no hemodynamic support" 
Current Progress on Statement of Work
A Gantt chart of the current work is provided in Table 2 for reference (page 7). The months in the approved statement of work (Table 1) do not necessarily match with the Gantt chart (Table  2) , since the latter reflects actual work completed in each year. Aim 1. Determine the acute vascular, metabolic, and pressure responses to SCI and longterm functional outcome. "SCI with no hemodynamic support"
• Task 1: Submit documents for ACURO approval
Completed. A CURO approval was granted 26-MARCH-2015.
• Task 2: Characterize the intraparenchymal metabolic, blood flow, and pressure changes that occur during the first 24 hours post-injury with no hemodynamic resuscitation before or after decompression
Completed.
• Task 3: Determine the long-term functional and histologic outcome of SCI with no hemodynamic resuscitation before or decompression
In progress.
• Task 4: Evaluate the metabolomic changes that occur within the spinal cord and surrounding CSF and compare these with metabolomic changes within human CSF
In progress.
Aim 2. Determine the effects of aggressive hemodynamic support during sustained spinal cord compression on the acute physiologic responses to SCI and long-term functional outcome. "SCI with SCI with hemodynamic support during compression"
• Task 1: Characterize the intraparenchymal metabolic, blood flow, and pressure changes that occur during the first 24 hours post-injury with aggressive hemodynamic support provided during sustained spinal cord compression
• Task 2: Determine the long-term functional and histologic outcome of SCI when aggressive hemodynamic support is provided during sustained compression
• Task 3: Evaluate the metabolomic changes that occur within the spinal cord and surrounding CSF and compare these with metabolomic changes within human CSF
Aim 3. Determine the effects of aggressive hemodynamic support after spinal cord decompression on the acute physiologic responses to spinal cord injury and long-term functional outcome.
• Task 1: Characterize the intraparenchymal metabolic, blood flow, and pressure changes that occur during the first 24 hours post-injury with aggressive hemodynamic support provided after spinal cord decompression
• Task 2: Determine the long-term functional and histologic outcome of SCI when aggressive hemodynamic support is provided after cord decompression
In progress. 
OVERALL PROJECT SUMMARY
This grant is focused on the augmentation of MAP with vasopressors and determining how such MAP augmentation would best be implemented (during compression, after decompression, or both). One of the issues that we felt needed to be addressed at the outset was to determine which vasopressor to use in order to actually accomplish this MAP augmentation. In Year 2 of this grant we finalized a head-to-head comparison of two commonly used vasopressors, norepinephrine (NE) and PE (PE) after SCI to determine how these commonly used vasopressors affects spinal cord oxygenation (luminescence-based optical sensor), perfusion (laser-Doppler flowmetry), intraparenchymal pressure (fiber optic probe) and downstream metabolic responses (microdialysis) (See Appendix 1. page 18 for manuscript draft). For this study we used female Yorkshire pigs subjected to a combination of contusion trauma and compression at the T10 level.
Using PE or NE, MAP was augmented by 20 mmHg above pre-SCI levels. reaching target levels of around 75-85 mmHg. In summary, MAP augmentation of -20 mm Hg was achieved comparably between PE and NE. Correlation analysis revealed that changes in MAP during NE and PE in the compressed state of the spinal cord were not associated with positive changes in neither SCBF nor PaP02. Notably during the decompressed state, there was no relation between changes in MAP and SCBF with PE, while an almost linear correlation existed with the use of NE. Additionally, an augmentation of SCBF correlated directly to positive changes in PaP02 using NE, which was contrary to PE. Notably, glutamate and UP ratio levels were significantly lower with the use of NE during decompression compared to no infusion, 1 hour after infusion had stopped indicative of reduced glutamate toxicity and ischemia. This is most likely due to the improved perfusion after decompression as observed with NE. These results suggest that NE may be preferable to PE if vasopressor support is required post SCI to maintain elevated MAPs in accordance with published guidelines. See Appendix 1, page 18 for manuscript draft.
Results
We recently finalized the histological analysis of the spinal cords of these animals (Eriochrome Cyanine R Staining). After collection of the spinal cords, segments were cryoprotected using a graded concentrations of sucrose (6, 12, 24% sucrose in 0.1 M Phosphate Buffer each for 48 hours). The tissue was then embedded in Tissue-TekTM CRYO-OCT compound (Sakura Finetek, Torrance, CA) and frozen before being cut into serial 20 µm thick transverse sections using a cryostat. Every other section was mounted on a series of 1 Ox silane coated slides, such that the adjacent sections mounted on each slide represented regions spaced 400 µm apart. For differentiating grey and white matter, Eriochrome Cyanine R staining was performed on spinal cord sections, which specifically stains myelin sheaths blue. Briefly, sections were dehydrated in an ethanol series, cleared in xylene, rehydrated in a reverse ethanol series followed by distilled water (dH20), then left in a solution containing 0.16% Eriochrome Cyanine R, 0.5% sulphuric acid and 0.4% iron chloride (in dH20) to stain myelinated fibres. Following staining, sections were differentiated in 0.5% ammonium hydroxide. After differentiation, the grey matter was counterstained in Neutral Red then rinsed in dH20. Finally, sections were dehydrated and cleared, as above, and then mounted onto silane-coated Superfrost-Plus slides (Fisher Scientific, Pittsburgh, PA).
Our analysis shows that near the epicenter the amount of tissue damage tend to be increased in the PE group compared to the control animals ( Figure 1 ). In the NE group a similar increase in tissue damage was observed, but to a lesser extent compared to the PE group (Figure 1 ). Whether the increased extent of tissue damage will account for poorer functional recovery is currently unknown (this question will be further addressed in AIM 1-3 of this grant). In summary, we found that NE was the most 'optimal' vasopressor and provided a better improvement in blood flow and PaP02 within the injured spinal cord compared to PE. Based on these findings we will use NE in Aim 2 and Aim 3 to determine the effects of aggressive hemodynamic support after SCI on the acute physiologic responses as well as long-term functional outcome.
In our first animals to be studied to address Aim 2 and 3 (animals A and B, Table  3 ) suggested to us that this dramatic rise in the MAP was most likely related to the Ephys procedure and the anaesthesia protocol used for this. We could not find precedent for this MAP problem in the E-phys literature using rat or mouse models. e However, based on these observations, we have dropped the E-phys recordings from our study and included 1-0.5% isoflurane to the anesthesia protocol. We continued with the scheduled surgeries as outline in Table 3 . ***Notably, in our award we proposed 3 hours of compression and another 3 hours of decompression with or without MAP support of 20 mm Hg. However, by the end of this 6-hour period, the animal has been under anaesthesia for close to 18 hours, has undergone an extensive laminectomy, and has lost a considerable amount of blood. Hence, we intend 1 hour of compression and another 1 hours of decompression instead, to reduce the risk for serious health complications when animals recovering from anesthesia.
Besides measuring spinal cord pressure, oxygenation and blood flow, we have now also established the technique to accurately monitor MAP changes over a 7-day period. To accomplish this, we tunnelled the arterial catheter underneath the skin ( Figure 2A ) to avoid abscess and infection at the incision site. Additionally, to ensure accuracy, the pressure transducer was sutured at the level of the right atrium instead of attaching it to the moving harness, and is now covered with a stable protector ( Figure 28 -yellow). The pressure transducer measuring MAP is sutured at the level of the heart directly to the pig to avoid movement affecting MAP readings and covered with a yellow protector. (C) Mean arterial pressure and heart rate data recorded over a 7-day period of pig ID# 8568 (left) and 10#8567 (right). Grey shading:
represents NE Infusion.
• 8St:63mmH;
In summary, we have performed 4 additional surgeries (Table 3 : M-P; highlighted in blue). Additional surgeries are scheduled up to December of this year. We will continue with the rest of the animals in the four infusion groups (n=12) and will finish these surgeries by the end of 2016.
KEY RESEARCH ACCOMPLISHMENTS
• Proximal to the impact, NE and PE resulted in only a modest improvement in SCBF during cord compression; however, levels remained well below pre-injury values.
• During the decompressed state, NE resulted in increased SCBF and PaP02 levels, while a decrease was observed for PE.
• Distal to the impact, both vasopressors increased SCBF and PaP02 above preinjury levels, with minimal apparent effect on the downstream metabolic state of the cells.
• SCBF continued to rise in the PE group even after infusion was ceased.
• Tissue damage tend to be increased in the PE group compared to the control animals • In the NE group a similar increase in tissue damage was observed, but to a lesser extent compared to the PE group
CONCLUSION
This research focuses on the acute hemodynamic management of spinal cord injury and specifically addresses the current practice of aggressively maintaining the mean arterial pressure (MAP) at 85-90 mm Hg for 5-7 days post-injury. This has particular relevance to military personnel who are injured in combat zones. Our data advanced our current understanding of the pathophysiology following spinal cord injury, and in Year 3 the focus of this study is to finalize the cohort of animals evaluating the consequences of hemodynamic support on intraparenchymal SCBF, oxygenation and downstream metabolic responses after SCI as well as functional recovery. Abstract: Traumatic spinal cord injury (SCI) results in local and systemic vascular changes, which make the spinal cord extremely vulnerable to ischemia, hypoxia, and energy dysfunction. Current guidelines recommend maintaining a mean arterial pressure (MAP) of 85-90 mmHg using volume expansion agents and vasopressors in an attempt to support the injured spinal cord with adequate perfusion. While the desire to prevent ischemia is understandable, indiscriminate augmentation of MAP in a traumatically injured cord with impaired vascular autoregulation may have deleterious effects. In this study we sought to determine the impact of MAP augmentation on vascular and metabolic responses as well as long-term behavioral outcomes following a contusion-compression injury of the spinal cord.
PUBLICATIONS, ABSTRACTS AND PRESENTATIONS
Using our porcine model of SCI, female Yucatan miniature pigs received a T1 O contusion injury followed by 3-hours of sustained compression. 1-hour postcompression and decompression, norepinephrine (NE) was used to elevate MAP by 20 mmHg for a 1.0-hr period. Laser Doppler/oxygenation and pressure probes were inserted into the spinal cord 0.2 and 2.2 cm from the injury site to monitor the effects of MAP support on spinal cord blood flow (SCBF), PaP02, pressure over a 7-day period. Microdialysis samples were also collected and subsequently analyzed for lactate, pyruvate, glucose, glutamate and glycerol. Behavioral recovery was scored weekly according to the Porcine Thoracic Injury Behavioral Scale (PTIBS). Data from the first 6 hours after SCI showed that proximal to the impact (0.2-cm location), NE infusion during the compressed and decompressed state of the spinal cord resulted in only a slight restoration of SCBF and Pa02, though both still remained well below pre-injury levels. In the decompressed state, a decrease in UP ratio was observed in the NE group to -250% of pre-injury levels, while levels remained unaltered in the control group (-800% of pre-injury). Distal to the impact (2.2-cm location), NE infusion increased SCBF and PaP02 above pre-injury levels both during the compressed and decompressed state of the spinal cord. Currently we are analyzing the intraparenchymal responses during the subsequent 7 days as well as the long-term behavioral consequences of MAP support.
Combined, our preliminary results suggest that MAP augmentation during compression and following decompression could partially restore post-traumatic ischemia/hypoxia at the injury site, but could potentially lead to hyperemia distal to the injury site. Identifying the functional consequences is currently being carried out. There are, however, no formal recommendations regarding the optimal agent in acute SCI. The decision about which vasopressor to use in acute neurotrauma is typically left to the discretion of the treating physician, whose choice may be based on desired pharmacologic activity, personal familiarity/experience, and institutional bias/tradition.
This has resulted in considerable variations in clinical practice for both traumatic brain injury (TBI) and SCI. For example, a retrospective study of pediatric TBI patients at a single American level 1 trauma canter reported that vasoprassor usage varied widely, with the first-line treatment most commonly being PE (57%), followed by DA (29%), NE (10%), and epinephrine (4%). 6 In a series of 114 adult TBI patients from the same institution, PE was again the most commonly used vasopressor (43%), followed by NE (30%), DA (22%), and vasopressin (5%). 7 In a series of 131 acute SCI patients at another American level 1 trauma center, DA was the most commonly used vasopressor (48%), followed by PE (45%), NE (5.0%), epinephrine (1.5%) and vasopressin (0.5%). 8 In contrast, at our local institution and in other Canadian institutions, the vasopressor of choice is NE, followed by DA These observed variations in practice simply highlight the equipoise that exists with respect to vasopressor usage in acute SCI and TBI.
While all of these vasopressors can effectively increase MAP, they each have unique pharmacologic properties, based on their affinity for alpha-adrenergic, beta-adrenergic, dopamine, and vasopressin receptors. As such, it is reasonable to expect that they would have different effects on perfusion within the injured central nervous system (CNS). 9 NE is a potent alpha-adrenergic agonist with less pronounced beta-adrenergic agonist effects. NE increases MAP primarily by peripheral vasoconstriction but also potentially increasing cardiac output through beta1-mediated inotropy. DA has dose-dependent effects, with dopaminergic effects at low doses and mixed alpha-and beta-adrenergic effects at higher doses, causing vasoconstriction and increased cardiac output. PE, a selective alpha1-adrenergic agonist, increases MAP primarily by peripheral vasoconstriction. Its rapid onset, short duration, and primary vascular effects make it an attractive agent in the management of hypotension.
However, because of its isolated alpha1 effects, PE can lead to reflex bradycardia and decreased cardiac output, leading to worsened tissue perfusion. 10 Although these well-described profiles characterize the overall cardiovascular effects of vasopressors, their effects on specific vascular beds within the CNS may not be so predictable, particularly after injury. Therefore in this study we performed a head-to-head comparison of NE, and PE after SCI to determine how these commonly used vasopressors affects spinal cord oxygenation (luminescence-based optical
Methods
All animal protocols and procedures employed in this study were approved by the Animal Care
Committee of the University of British Columbia and were compliant with the policies of the Canadian Council on Animal Care.
Anlmals & experlmental grouping
Female Yorkshire pigs (local distributor) weighting 25-32 kg were transported to our animal facility 1 week before surgery. Upon arrival, the animals were housed in groups of 2-4 in an indoor pen bedded with sawdust and toys (chains, balls) with access to an adjoining outdoor pen. Animals were given water ad libitum and fad 1.5% of their body weight twice a day (Mazuri Mini-Pig Youth, PMI Nutrition International, Brentwood MO, USA). On the day of surgery, animals ware distributed into three groups: 1) SCI-NE group, n=9 2) SCI-PE group, n=9, and 3) SCI-controls, n=4. All three groups received a T10 contusion injury followed by 3 hours of compression and then 3 hours of post-decompression. During each 3-hour period, the SCI-NE and SCI-PE group received a 1-hour infusion of NE (4 mg in 250 ml of 0.9% salina/1.25% dextrose) or PE (1 ml in 250 ml of 0.9% salina/1.25% dextrose) respectively to raise MAP 20 mmHg and measure responses inside the injured cord. The SCI-control group received no vasopressor infusion. During vasopressor infusion, l.V. maintenance fluids rates (0.9% NaC/1.25% dextrose) were independently adjusted to ensure a total fluid infusion of 7ml/kg/hr for all three experimental groups.
Catheterization of the carotid artery and jugular vein
Tracheal intubation and mechanical ventilation was performed as described previously. 17 Anesthesia was maintained with a combination of isoflurane (0.5% in 100% 0 2 ) and propofol (8-20 mg/kg/hr; Baxter, Allison, Ontario, Canada). All animals received ketoprofen (3 mg/kg) via intravenous administration and fentanyl (15-30 g/kg/hr; Sandoz Canada, Boucherville, Quebec, Canada) delivered via continuous rate infusion (CRI). After a surgical plane of anesthesia was reached, the animal was placed on the surgical table in the supine position. Using a scalpel, a longitudinal incision was made -3 cm left of the midline.
After the parivascular connecting tissues ware carefully removed by blunt dissection, catheter was inserted into the left external jugular vain (EJV) for the application of drugs and into the common carotid artery (CCA) for the measurement of MAP. After exposure of the CCA, a 14 gauge i.v. catheter was inserted, which was then connected to a blood pressure transducer system (Edward Lifesciences Inc, Irvine, CA). After the EJV was ligated, a 7F triple lumen venous catheter (Arrow International, Reading, PA) was inserted and advanced -16 cm towards the heart. To secure both catheters, two ligatures caudal to the site of insertion were carefully tied around the vessels in addition to being sutured to the musculature. The wound was closed in layers with the catheters exiting the skin through the primary incision site.
Porcine model of SCI
After catheter insertion, the animal was rotated into a prone position. A skin incision was made along the dorsal midline of the thoracic region of each animal. Using electro-cautery (Surgitron® Dual Frequency RF/120 Device; Ellman International, Oceanside, NY), the semispinalis, multifidus and longissimus lumborum muscles were separated from the dorsal spinous processes, laminae and transverse processes. A T9 to T13 laminectomy was performed and widened to expose the dura and spinal cord with sufficient clearance for sensor insertion and weight drop injury.
The SCI was delivered by a weight drop impactor device, which was securely fixed to the spine using an articulating arm (660, Starrett, Athol, Massachusetts, USA) mounted via bilaterally inserted T6 and T8 pedicle screws. This arm enabled the guide-rail to be precisely positioned and aligned, allowing for the impactor to fall straight vertically onto the exposed dura and cord at T10. The tip of the impactor Samples were analyzed within a weak of collection using the ISCUS 
Data analysis
SCBF and PaP0 2 were recorded continuously at a sampling rate of 10 Hz during baseline recording and for 3 hours after SCI. Thereafter the sampling rate was reduced to 1/6 Hz, as the sensor carries only a limited supply of the ruthenium lumiphor. To mitigate movement artifacts in the oxygenation and blood flow data, a post-processing filter was applied (smoothing type: median filter, window width: 601 samples / 1 minute of sampling). Microdialysis samples were collected every 15 minutes, from the beginning of the baseline period to 6 hours post-injury. These duplicate values were averaged for each time point. The delay from microdialysis catheter tip to collecting vial was 12 minutes, and this was accounted for when analyzing the results. The lactate to pyruvate (UP) ratio was calculated from the measured values of lactate and pyruvate concentrations. To account for absolute differences in the baseline recordings, all values ware expressed as a percentage change from baseline (%.6.) as a function of time (hours). For comparisons of three independent groups, the Kruskal-Wallis test followed by Dunn's post hoc test was used. Between group differences at each time point was determined using multiplet-test. Calculated pvalues were corrected for multiple testing using Bonferroni adjustment. Differences between groups were considered significant if more then two consecutive points in the time course were statistically significant at p < 0.05. Results are expressed as mean values ±SEM, with correlations between parameters determined using Spearman correlation coefficients with Bonferroni correction (GraphPad Prism 6).
Results

Validation of the impact across the experimental groups
All animals received a contusion SCI by dropping a 50 g weight from a 20 cm height at the T10 level of the spinal cord followed by 3 hours of compression (150 g total weight). To determine the consistency of the injury, we measured force, displacement and velocity of the impact. On average the maximum impact force applied to the exposed spinal cord measured at the tip of the impactor was 3315 ± 119 kdynes. The impactor tip traveled 3.1 ± 0.1 mm from initial contact with the exposed dura with a velocity of 1,701 ± 1306 mm/sec at impact. Between the experimental groups no significant differences were observed (p>0.05)<Table 1 ).
Physlologlcal parameters
To maintain a target MAP of 20 mmHg above pre-SCI levels (i.e. target MAP: of 75-85 mmHg; Figure 1A ), the average PE dose was 0.7 + 0.1 (range 0.14-2.8) mcg/kg/min, and NE dose was mmHg, although this was less in the SCI-PE group compared to SCI-NE group. Vasopressor infusion had minimal effect on PaP0 2 during the compressed state, independent on which vasopressor was used.
Following decompression, SCBF and PaP0 2 levels recovered partially for all three groups, although the extent was much greater in both vasopressor groups. In the decompressed state only NE was able to increase both SCBF and PaP0 2 , while PE infusion resulted in a drop of SCBF. Compression of the spinal cord resulted in increased intraparenchymal SCP to 300-600% above pre-injury levels in all three experimental groups, which rapidly declined after decompression. MAP augmentation by 20 mmHg with PE or NE did not seem to effect SCP values.
Post-injury Changes in Microdialysis Markers:
Time-dependent changes in microdialysis markers of cellular distress (glutamate and glycerol) and energy metabolism (glucose, lactate, and pyruvate) induced by the injury are summarized in Figure 3 . Glucose levels in the SCI-control group rapidly decreased after contusion to <10% of pre-injury values and steadily decreased to almost zero at the end of the 3-hour compression period ( Figure 3A) . Decompression was associated with a small increase in glucose, yet levels persisted wall below pre-injury values (-25%). In contrary to the gradual drop in glucose levels for the SCI-control group during the 3-hours of compression, glucose held steadily at around 20% above preinjury values during the 1-hour infusion period in both the SCI-PE and SCI-NE group. For the first 45 minutes aft.er vasoprassor infusion was ceased, glucose levels tended to be higher in the SCI-NE group compared to the SCI-control animals (p<0.05). During the compression period, the glucose response was similar across the 3 groups.
Glutamate levels sharply increased aft.er SCI , reaching peak values of -3000% within 15 minutes after contusion <Figure 38). For the SCI-control group, glutamate levels remained >2000% throughout the 6 hour observation period. During the compressed state of the spinal cord, augmenting MAP resulted in negligible changes in glutamate levels in the SCI-PE and SCI-NE group. However, following decompression the SCI-NE group demonstrated a decreasing trend within 45 minutes after decompression (notably 15 minutes before vasopressor infusion). Glutamate decreased to 600% and remained at this level during the 1-hour period following cessation of NE infusion. Compared to the SCIcontrol group, glutamate values in the SCI-NE group were significantly (p<0.05) lower 0.5 hours after decompression and during the second NE infusion. Although the decline in glutamate was numerically more in the SCI-NE than the SCI-PE (mean percent change -1000% vs. -500%), the difference was not statistically significant.
Glycerol levels exhibited a peak value of -317% within 30 minutes after contusion and remained at this level throughout the compression period ( Figure 3C ). Immediately after decompression, levels rose again and remained high at -500-650% till the end of the study. For the SCI-PE and SCI-NE group, the acute change in glycerol as a result of the SCI (i.e. prior to the first vasopressor infusion) was significantly less.
Notwithstanding the lower SCI values, PE and NE infusion had no apparent effect on glycerol levels.
In the SCI-control group, elevated lactate ( Figure 30 ) and decreasing pyruvate levels ( Figure 3E ) were observed during the compression period, resulting in a marked rise in LIP ratio ( Figure 3F ). After decompression, both lactate and pyruvate levels steadily increased, but then decreased again. As lactate levels did not change in direct proportion to pyruvate, L/P ratio gradually declined to -450%. As in the SCI-control group, a similar increase in LIP ratio was observed acutely after SCI and during the 3-hour compression period for both the SCI-PE and SCI-NE group, without significant changes during gradually continued to increase even after infusion was stopped until the end of the experiment.
Vasopressor infusion did not have a noticeable effect on intraparenchymal pressure ( Figure 4C ). ... 
